H
Huiqing Cao
Researcher at Peking University
Publications - 56
Citations - 2076
Huiqing Cao is an academic researcher from Peking University. The author has contributed to research in topics: Gene & Gene silencing. The author has an hindex of 23, co-authored 53 publications receiving 1678 citations. Previous affiliations of Huiqing Cao include Peking Union Medical College & University of Tennessee Health Science Center.
Papers
More filters
Journal ArticleDOI
Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations.
Yang Li,Wen-Jing Wang,Huiqing Cao,Jiehua Lu,Chong Wu,Fang-Yuan Hu,Jian Guo,Ling Zhao,Fan Yang,Yi Xin Zhang,Wei Li,Gu-Yan Zheng,Hanbin Cui,Xiaomin Chen,Zhiming Zhu,Hongbo He,Birong Dong,Xianming Mo,Yi Zeng,Yi Zeng,Xiao-Li Tian +20 more
TL;DR: It is demonstrated that, unlike FOXO3A, FOXO1A is more closely associated with human female longevity, suggesting that the genetic contribution to longevity trait may be affected by genders.
Journal ArticleDOI
Long non-coding RNA ANRIL regulates inflammatory responses as a novel component of NF-κB pathway.
Xiao Zhou,Xiaorui Han,Ann Wittfeldt,Jingzhi Sun,Chu-Jun Liu,Xiaoxia Wang,Li-Ming Gan,Huiqing Cao,Zicai Liang +8 more
TL;DR: The newly identified TNF-α-NF-κB-ANRIL/YY1-IL6/8 pathway enhances understanding of the etiology of CAD and provides potential therapeutic target for treatment of CAD.
Journal ArticleDOI
Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis.
TL;DR: It is demonstrated that Malat1 modulates Srf through miR‐133 as a competing endogenous RNA in myogenesis and established a novel connection among Malat 1, miR-133, and Srf in myoblast differentiation.
Journal ArticleDOI
A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer
Lei Zhang,Ye Xu,Xingyu Jin,Zengwu Wang,Yidi Wu,Deyao Zhao,Gang Chen,Deyu Li,Xiaoxia Wang,Huiqing Cao,Yuntao Xie,Zicai Liang +11 more
TL;DR: The data demonstrate that the SdM-RT-PCR assay is an effective breast cancer profiling method that utilizes very small volumes and is compatible with Biobank and the identified 3-miRNA signature is a promising circulating biomarker for breast cancer diagnosis.
Journal ArticleDOI
The Promising Nanocarrier for Doxorubicin and siRNA Co-delivery by PDMAEMA-based Amphiphilic Nanomicelles.
Qiang Cheng,Lili Du,Lingwei Meng,Shangcong Han,Tuo Wei,Xiaoxia Wang,Yidi Wu,Xinyun Song,Junhui Zhou,Shuquan Zheng,Yuanyu Huang,Xing-Jie Liang,Huiqing Cao,Anjie Dong,Zicai Liang +14 more
TL;DR: PECD micelles have a potential ability as DOX and siRNA co-delivery carrier for cancer therapy, according to the results of drug release profile in acidic media, flow cytometry analysis and confocal images.